Form 4: GE HealthCare Technologies Inc.: Officer O'Neill Reports Stock Transactions
SEC Form 4 Filing
Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 1, 2025, Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reported a transaction involving common stock.
- 2,140 shares of common stock were disposed of at a price of $87.35 per share to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, O'Neill directly owns 19,875 shares of GE HealthCare Technologies Inc. common stock.
- O'Neill also indirectly owns 59 shares through a share incentive plan trust.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It is a common practice for companies to withhold shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of stock transaction (disposal of shares for tax withholding). |
| 03/04/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.